ScoutQuest12 Oct 2026
Jubilant Pharmova530019NCD issuance

Board approves NCD issue of up to ₹800 crore, seeks members' nod for ₹2,500 crore debt securities

Board approved issuing up to 80,000 non-convertible debentures of face value ₹1,00,000 each, aggregating up to ₹800 crore, on a private placement basis.

NCD Issue Size
up to ₹800 crore
Number and Face Value of NCDs
up to 80,000 non-convertible debentures of face value ₹1,00,000 each
Members' Approval Limit
non-convertible debt securities up to ₹2,500 crore outstanding at any point of time, within one year of the resolution

Board Meeting Outcome

The board of the company met on October 12, 2026 and approved raising money through non-convertible debentures (NCDs) on a private placement basis. An NCD is a debt instrument: the company borrows money from investors and commits to pay interest and repay the principal on maturity. On a private placement basis means the debentures are offered to select investors rather than to the general public.

What the board approved

Key terms as stated in the disclosure

Members' approval being sought

Through a Special Resolution by Postal Ballot, approval of the members is being sought for issuance of non-convertible debt securities on a private placement basis, for an aggregate amount not exceeding ₹2,500 crore outstanding at any point of time, during a period of one year from the date of passing of the Special Resolution.

How to read the two numbers

The ₹800 crore figure is the specific NCD issue the board has approved, made up of 80,000 debentures of ₹1,00,000 face value each. The ₹2,500 crore figure is the outer limit of non-convertible debt securities the company would be authorised to keep outstanding at any point of time over one year, once members pass the resolution. The board meeting commenced at 11:00 A.M. and concluded at 12:15 P.M.

More numbers
  • Number of NCDs proposed to be issued80,000
  • Face value per NCD₹1,00,000
  • Aggregate size of the approved NCD issue₹800 crore
  • Limit for non-convertible debt securities under members' approval₹2,500 crore
  • Tenure of the NCD instrumentUpto five years
Source: BSE · 12 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.